HomeNMRD • OTCMKTS
add
Nemaura Medical Inc
Previous close
$0.00
Market cap
40.00 USD
Avg Volume
9.04K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.54M | -5.09% |
Net income | -2.16M | -25.94% |
Net profit margin | — | — |
Earnings per share | -0.12 | -71.43% |
EBITDA | -1.46M | 4.39% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.42K | -98.13% |
Total assets | 5.17M | -60.12% |
Total liabilities | 23.00M | 0.77% |
Total equity | -17.83M | — |
Shares outstanding | 28.90M | — |
Price to book | -0.00 | — |
Return on assets | -54.70% | — |
Return on capital | -112.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -2.16M | -25.94% |
Cash from operations | -1.48M | 3.99% |
Cash from investing | -10.43K | 81.91% |
Cash from financing | -3.00M | -76.51% |
Net change in cash | -4.24M | -53.16% |
Free cash flow | 1.19M | 170.82% |
About
Nemaura Medical Inc. is a UK based Medical Technology company developing a wireless non-invasive blood glucose monitoring system called SugarBeAT. Wikipedia
Founded
2013
Website
Employees
36
